Zhongzhi Pharmaceutical Holdings Yönetim
Yönetim kriter kontrolleri 3/4
Zhongzhi Pharmaceutical Holdings CEO'su Ying Feng Lai, Mar2021 tarihinde atandı, in görev süresi 3.67 yıldır. in toplam yıllık tazminatı CN¥ 1.39M olup, şirket hissesi ve opsiyonları dahil olmak üzere 79% maaş ve 21% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.69% ine doğrudan sahiptir ve bu hisseler HK$ 5.27M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.7 yıl ve 9.4 yıldır.
Anahtar bilgiler
Ying Feng Lai
İcra Kurulu Başkanı
CN¥1.4m
Toplam tazminat
| CEO maaş yüzdesi | 79.0% |
| CEO görev süresi | 3.7yrs |
| CEO sahipliği | 0.7% |
| Yönetim ortalama görev süresi | 3.7yrs |
| Yönetim Kurulu ortalama görev süresi | 9.4yrs |
Son yönetim güncellemeleri
Recent updates
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding
Aug 22
Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Jun 19Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation
May 10Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
May 05Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
Apr 21Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares
Feb 01These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)
May 06Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues
Apr 21Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?
Mar 29The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More
Mar 05Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 15
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?
Jan 14Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?
Dec 27If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late
Dec 14Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?
Nov 30Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 17CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥111m |
| Mar 31 2024 | n/a | n/a | CN¥137m |
| Dec 31 2023 | CN¥1m | CN¥1m | CN¥163m |
| Sep 30 2023 | n/a | n/a | CN¥164m |
| Jun 30 2023 | n/a | n/a | CN¥164m |
| Mar 31 2023 | n/a | n/a | CN¥135m |
| Dec 31 2022 | CN¥1m | CN¥802k | CN¥106m |
| Sep 30 2022 | n/a | n/a | CN¥84m |
| Jun 30 2022 | n/a | n/a | CN¥63m |
| Mar 31 2022 | n/a | n/a | CN¥57m |
| Dec 31 2021 | CN¥1m | CN¥791k | CN¥52m |
| Sep 30 2021 | n/a | n/a | CN¥93m |
| Jun 30 2021 | n/a | n/a | CN¥133m |
| Mar 31 2021 | n/a | n/a | CN¥136m |
| Dec 31 2020 | CN¥1m | CN¥801k | CN¥139m |
| Sep 30 2020 | n/a | n/a | CN¥133m |
| Jun 30 2020 | n/a | n/a | CN¥128m |
| Mar 31 2020 | n/a | n/a | CN¥121m |
| Dec 31 2019 | CN¥986k | CN¥700k | CN¥115m |
| Sep 30 2019 | n/a | n/a | CN¥106m |
| Jun 30 2019 | n/a | n/a | CN¥97m |
| Mar 31 2019 | n/a | n/a | CN¥91m |
| Dec 31 2018 | CN¥603k | CN¥274k | CN¥85m |
Tazminat ve Piyasa: Ying Feng 'ın toplam tazminatı ($USD 195.29K ) Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 235.95K ).
Tazminat ve Kazançlar: Ying Feng şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.
CEO
Ying Feng Lai (32 yo)
3.7yrs
Görev süresi
CN¥1,385,000
Tazminat
Mr. Ying Feng Lai has been Executive Director of Zhongzhi Pharmaceutical Holdings Ltd since May 14, 2018 and serves as its Chief Executive since March 24, 2021. Mr. Lai joined the Group since April 2014 an...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman | 9.8yrs | CN¥1.92m | 60.33% HK$ 458.5m | |
| Chief Executive & Executive Director | 3.7yrs | CN¥1.39m | 0.69% HK$ 5.3m | |
| CFO & Executive Director | 3.7yrs | CN¥1.16m | Veri yok | |
| Deputy GM & Executive Director | 3.7yrs | CN¥1.36m | 0.38% HK$ 2.8m | |
| Company Secretary | 7.5yrs | Veri yok | Veri yok |
3.7yrs
Ortalama Görev Süresi
42yo
Ortalama Yaş
Deneyimli Yönetim: 3737 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.7 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman | 9.8yrs | CN¥1.92m | 60.33% HK$ 458.5m | |
| Chief Executive & Executive Director | 6.5yrs | CN¥1.39m | 0.69% HK$ 5.3m | |
| CFO & Executive Director | 2.7yrs | CN¥1.16m | Veri yok | |
| Deputy GM & Executive Director | 9.8yrs | CN¥1.36m | 0.38% HK$ 2.8m | |
| Independent Non-Executive Director | 9.4yrs | CN¥162.00k | Veri yok | |
| Non-Executive Director | 10.2yrs | CN¥270.00k | 4.89% HK$ 37.2m | |
| Independent Non-Executive Director | 9.4yrs | CN¥162.00k | Veri yok | |
| Independent Non-Executive Director | 9.4yrs | CN¥162.00k | Veri yok |
9.4yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 3737 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.4 yıldır).